Form 4: Vericel Corp Director Alan Rubino Reports Stock Transactions

Director Alan Rubino reports acquisition of Vericel Corp common stock through vesting of Restricted Stock Units and grant of stock options.

Summary

• On May 1, 2024, Alan Rubino, a director of Vericel Corp, reported transactions involving the company's stock.
• Rubino acquired 3,200 shares of common stock through the vesting of Restricted Stock Units (RSUs) granted on May 3, 2023.
• Additionally, Rubino was granted stock options to purchase 8,000 shares of common stock at a price of $47.08, exercisable starting May 1, 2024, and expiring on May 1, 2034.
• Rubino also acquired 3,200 Restricted Stock Units (RSUs) that vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.
• Following these transactions, Rubino directly owns 23,794 shares of Vericel Corp common stock and 8,000 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of shares and options could be seen as a slightly positive sign, but it's not definitively bullish.

Positives

• The acquisition of shares through RSU vesting and the grant of stock options could be seen as a positive sign, indicating the director's alignment with the company's future success.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs and the exercisability of the stock options suggest a continued relationship between the director and the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares upon option exercise or RSU vesting.

Key Dates